GlaxoSmithKline drops plan to sell off older drugs business | Business Information & News | Westlaw

GlaxoSmithKline drops plan to sell off older drugs business | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, GlaxoSmithKline drops plan to sell off older drugs business, Business Information & News
12/4/14 REUTERS 19:18:36
REUTERS
Copyright © 2014 Thomson Reuters
December 4, 2014
GlaxoSmithKline drops plan to sell off older drugs business
Ben Hirschler
LONDON (Reuters) - GlaxoSmithKline said on Thursday it had decided not to sell a portfolio of older drugs marketed in North America and Europe after considering offers from potential buyers.
"The company has evaluated all bids received and has...
---- Index References ----
Company: LAZARD LTD; H LUNDBECK AS; GLAXOSMITHKLINE PLC; SANOFI SA; NOVARTIS INC; APOLLO GLOBAL MANAGEMENT LLC
News Subject: (Major Corporations (1MA93))
Industry: (Pharmaceuticals (1PH33); Pharmaceuticals & Biotechnology Industry Highlights (1PH07); Pharmaceuticals & Biotechnology (1PH13))
Region: (Europe (1EU83); United Kingdom (1UN38); Western Europe (1WE41); England (1EN10))
Language: EN
Other Indexing: (Andrew Witty; Toby Melville)
Keywords: securities; m&a; PrivateEquity; PrivateEquityFundFormation (MCC:OEC); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OEC)
Word Count: 437
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.